OXTR
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
CSN27602 | SHR1653 | 2231770-73-1 | SHR1653 is a highly potent oxytocin receptor antagonist with excellent blood-brain barrier penetration. It might be beneficial for the treatment of CNS-related premature ejaculation. |
CSN18548 | 5-(3-(3-(2-Chloro-4-fluorophenoxy)azetidin-1-yl)-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine | 900510-03-4 | PF-3274167 is a high-affinity nonpeptide oxytocin receptor OTR antagonist with Ki of 95 nM |
CSN22478 | OT antagonist 3 | 925703-75-9 | OT antagonist 3 is an oxytocin OT antagonist extracted from patent WO2007017752A1 |
CSN22477 | OT antagonist 1 | 479080-38-1 | OT antagonist 1 Compound 4 is a potent selective Oxytocin antagonist with a Ki of 50 nM |
CSN25228 | LIT-001 | 2245072-21-1 | LIT-001 is the first nonpeptide oxytocin receptor agonist. |
CSN22443 | L-368,899 hydrochloride | 160312-62-9 | L-368,899 HCl is a potent, selective, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC50s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively, used as a tocolytic agent. |
CSN22158 | Epelsiban | 872599-83-2 | GSK 557296 is a potent selective and orally bioavailable oxytocin receptor antagonist with a pKi of 99 for human oxytocin receptor |